Hero veteran James Topp sues legacy media journalist for slander
Canadian hero and veteran James Topp has sent Global News a libel notice for calling him a white supremacist in an article published in August. 

Keean Bexte

September 22, 2022

Canadian hero and veteran James Topp has sent Global News a libel notice for calling him a white supremacist in an article published in August. 

Hero veteran James Topp sues legacy media journalist for slander (Photo courtesy of James Topp)

The notice mentions journalist Rachel Gilmore, Global News and Corus Entertainment Inc. as defendants. 

“The defamatory article, inclusive of the URL tag, referred to Mr. Topp as a white supremacist, among other things,” wrote lawyer David Elmaleh. 

“(It was published) without providing any evidence supporting their statements.” 

Topp marched across Canada beginning in Vancouver to protest government vaccine mandates. On his journey he met with several prominent politicians including Conservative leader Pierre Poilievre. 

“We conduct ourselves with dignity, strength, and endurance at all times,” said Topp at a stop in Ontario.

“[If] you’re having issues, get a hold of somebody. Make sure you have water and food, mind the traffic, [and] be safe. Keep your head up, don’t block intersections, and, at all times, look out for each other.”

When first published, the Aug. 18 piece titled “Good PR’: Why anti-hate experts are urging politicians to step up vetting practices” had the words “white supremacist far right” beside Topp’s name in the URL. 

“(Defendants) also included various ‘tags’ on the defamatory article, further implying that Mr. Topp is a white supremacist, extremist and member of the far right,” wrote Elmaleh. 

“Take notice that Mr. Topp intends to plead that the defamatory words were made deliberately, irresponsibly and with malice.” 

“The intended defendants knew that the defamatory words, and the innuendo arising from them, were false, yet expressed them in any event in order to generate headlines, expand the reach of the defamatory article and garner interest from as many members of the public as possible.”

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Liberals admit they never had evidence that COVID vaccines stopped transmission of the virus.

Mike Campbell

June 4, 2024

Trending News

“I’m on pension. How am I going to pay for that?” asked Liz Diachun from Ontario after being hit with a $40,000 capital gains tax on her gift.

Keean Bexte

May 31, 2024

Trending News

After the COVID vaccines were coerced into about 85% of Canadians, including one that’s since been taken off shelves amid shocking adverse effect admissions, many have wondered if there was a connection between in-flight medical emergencies and the experimental shots that lacked long-term safety data. 

Mike Campbell

May 28, 2024

Trending News

A UK woman who was left paralyzed from the chest down after taking the ‘totally safe and effective’ AstraZeneca vaccine has been given $150,000 as compensation for her suffering.

Keean Bexte

May 27, 2024

Trending News

According to a 55-page ruling, the University of Colorado School of Medicine’s policy refusing religious exemptions to the vaccine mandate violated “clearly established” rights and was “motivated by religious animus”.

TCS Wire

May 21, 2024

Trending News

BC Supreme Court Justice Simon Coval ruled that extended vaccine mandates for healthcare workers were justified, adding that the mandates did obstruct certain freedoms, but those freedoms were secondary to “essential public health objectives.” 

Alexa Posa

May 15, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.